Project Grant 2145521

Award Date 4/15/22
Completion Date 3/31/27
Dollars Obligated $568K
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Athens, GA 30602, USA
Similar Awards
This $544,475 Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) aims to develop an in vitro cancer metastasis model system using decellularized organ-specific tissue (biomatrices) to study organ-specific cancer metastasis. The University of Texas Southwestern Medical Center, the awardee, hypothesizes that the biomatrices can recapitulate the organ microenvironment and enable the growth of organ-specific tumor colonies, which can be used to investigate...
This National Science Foundation Project Grant of $299,785 will fund research into the integrated effects of mechanical and biochemical factors on breast tumor invasion and metastasis. Awarded on September 1, 2022 under the Engineering program (CFDA 47.041), the grant supports a collaborative research project led by the University of Michigan from September 1, 2022 through August 31, 2025. Specifically, the research team will develop quantitative imaging biosensors and tissue-engineered breast...
This three-year, $681,444 National Science Foundation project grant supports collaborative research to develop tumor-mimetic collagen hydrogels for testing the role of structural cues on cancer cell migration. The Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded the funding under the Engineering program (CFDA 47.041), which aims to foster innovation and excellence in engineering research. The Rochester Institute of Technology will receive the award to create a...
This federal Project Grant award from the National Science Foundation's (NSF) Engineering program (CFDA 47.041) provides $575,000 to the New Jersey Institute of Technology (NJIT) to study how the microstructure and interstitial fluid pressure gradient in a bioprinted tumor-on-a-chip model can modulate cancer cell invasion. The 3-year project aims to create a tunable solid tumor model using light-assisted bioprinting and microfluidics technology to explore how matrix pore size, fluid-induced...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) to the Sloan-Kettering Institute for Cancer Research provides $577,034 in funding to investigate the interplay between the physical properties of the tumor microenvironment and the ability of cytotoxic lymphocytes to recognize and destroy cancer cells. The research will examine how distinct metastatic microenvironments (e.g. rigid bone, soft lung) affect the biomechanics of cancer cells...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) provides $214,583 to Tulane University to evaluate the role of the extracellular matrix (ECM) in triple-negative breast cancer (TNBC) tumor progression and treatment resistance. The research aims to 1) characterize how the TNBC ECM changes before and after chemotherapy treatment, and 2) use 3D in vitro and in vivo models to understand how the TNBC ECM impacts...
The National Science Foundation (NSF) awarded a 5-year, $539,532 CAREER (Faculty Early Career Development) grant to the University of Illinois to research predictive multiscale modeling of cell migration through pores between endothelial cells. The project will study the biomechanics and mechanobiology of transendothelial migration for three cell types: red blood cells, neutrophils, and tumor cells. Advanced computer simulations will be used to predict how different cell components affect the...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $180,632 to the University of Pittsburgh to conduct research aimed at halting breast cancer metastasis by blocking the engulfment of mesenchymal stem cells (MSCs) by cancer cells. The key objectives are: 1) Discovering and validating compounds that can block the cancer-MSC engulfment process using a high-throughput microfluidic assay and 3D cancer spheroid models, and 2) Unraveling...
This Project Grant award of $521,240 from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) aims to identify critical events within the premetastatic niche that facilitate breast cancer metastasis. The research team at Purdue University, with a sub-award to the University of Iowa, will use an engineered model of the premetastatic niche to understand how specific changes, such as in the extracellular matrix composition and extracellular vesicles, make distant tissues...
This Project Grant award, provided by the National Science Foundation's Mathematical and Physical Sciences (CFDA 47.049) program, supports collaborative research between Indiana University Indianapolis and Purdue University to develop a novel multi-scale 3D mathematical model to simulate cell migration. The $200,000 award will enable the researchers to integrate experimentally measured intracellular tension data into the model to better understand how external environmental factors, such as...

CAREER: IN VITRO MODEL APPROACHES LEVERAGING QUANTITATIVE CANCER CELL PROPERTIES AS DETERMINANTS OF METASTATIC POTENTIAL -CANCER METASTASIS OCCURS WHEN TUMOR CELLS BREAK AWAY FROM THE ORIGINAL TUMOR AND MOVE, OR SPREAD TO OTHER PARTS OF THE BODY. IN THE CASE OF BREAST CANCER, THE MAJORITY OF PATIENT DEATHS ARE AS A RESULT OF METASTASIS TO OTHER PARTS OF THE BODY, INCLUDING BONES, LUNG, AND BRAIN. THUS, IT IS IMPORTANT TO IDENTIFY CELLS THAT HAVE THE POTENTIAL TO BE METASTATIC CELLS EARLY AND RELIABLY. THIS CAREER PROPOSAL AIMS TO DEVELOP NOVEL STRATEGIES BASED ON MEASURING QUANTITATIVE PROPERTIES OF CANCER CELLS TO BETTER UNDERSTAND WHAT CONTRIBUTES TO METASTATIC CANCER AND WHAT SPECIFIC SIGNATURE METASTATIC CELLS HAVE THAT DISTINGUISHES THEM FROM NON-METASTATIC CELLS. THE PROPOSED WORK INTEGRATES A COMPREHENSIVE EDUCATION PLAN FOR MEETING THE PRIMARY OBJECTIVE OF INCREASING THE PARTICIPATION OF UNDERREPRESENTED MINORITIES IN BIOMEDICAL ENGINEERING. THIS PLAN WILL FOSTER AWARENESS AND INTEREST IN BIOMEDICAL ENGINEERING AND RESEARCH THROUGH RESEARCH MENTORING AND PROGRAMMING DEVELOPED TO PROVIDE EARLY AWARENESS OF BIOMEDICAL CAREER PATHS FOR STUDENTS. IN ADDITION, EDUCATIONAL OUTREACH EVENTS FOR ALL LEVELS WILL BE IMPLEMENTED, INCLUDING INITIATIVES FOR K-12 AND COLLEGE STUDENTS, AS WELL AS COMMUNITY-FOCUSED HEALTH & OUTREACH DAYS. THE INVESTIGATOR'S LONG-TERM RESEARCH GOAL IS TO DEVELOP STRATEGIES AND TOOLS THAT WILL HELP TO BETTER UNDERSTAND THE ROLE OF THE TUMOR MICROENVIRONMENT IN CANCER METASTASIS, WHICH WILL LEAD TO IMPROVED HEALTH OUTCOMES FOR PATIENTS WITH METASTATIC CANCER. TO MAKE SIGNIFICANT POSITIVE CONTRIBUTIONS TO CLINICAL OUTCOMES, IT IS NECESSARY TO FIRST HAVE A BETTER FUNDAMENTAL UNDERSTANDING OF CANCER CELL PROCESSES AND THE EFFECTS OF SPECIFIC FACTORS FROM THE TUMOR MICROENVIRONMENT ON CANCER CELL BEHAVIOR TO IDENTIFY METASTATIC CELLS EARLIER AND MORE RELIABLY. TOWARDS THIS GOAL, THIS CAREER PROJECT PRIMARILY FOCUSES ON UNDERSTANDING CONTRIBUTORS TO CANCER CELL METASTASIS, WITH A SPECIFIC FOCUS ON THE ROLE OF THE EXTRACELLULAR MATRIX (ECM) AND ADIPOSE-SECRETED FACTORS. THE RESEARCH OBJECTIVES OF THIS CAREER PROPOSAL ARE AIMED AT TESTING THE HYPOTHESIS THAT BREAST CANCER CELLS HAVE INHERENT PHENOTYPICAL CHARACTERISTICS ASSOCIATED WITH IMPEDANCE, MORPHOLOGY, AND GENE/PROTEIN EXPRESSION, WHICH DISTINGUISH METASTATIC CELLS FROM NON-METASTATIC CELLS. SPECIFICALLY, THE AIMS OF THIS WORK WILL: 1) ASSESS THE IMPEDANCE PROFILES FOR BREAST CANCER CELLS OF VARYING TYPE TO IDENTIFY DISTINCT IMPEDANCE SIGNATURES FOR SPECIFIC CELL TYPES; 2) IDENTIFY MORPHOLOGICAL FEATURES ASSOCIATED WITH BREAST CANCER CELL METASTASIS BY QUANTIFYING CHANGES IN CELL SHAPE; AND 3) ASSESS THE EFFECTS OF CYTOKINES ON BREAST CANCER METASTASIS USING IMPEDANCE AND MORPHOLOGY-BASED ANALYSES. QUANTITATIVE IN VITRO MODELING APPROACHES WILL BE APPLIED TO OBTAIN QUANTITATIVE DATA THAT WILL BE USED TO DELINEATE THE SPECIFIC SIGNATURE OF METASTATIC CANCER CELLS. DETERMINATION OF SPECIFIC CHARACTERISTICS USEFUL FOR IDENTIFYING METASTATIC CANCER CELLS WILL HAVE FAR-REACHING IMPACT FOR ADVANCING FUTURE CANCER RESEARCH AND CLINICAL APPLICATIONS. INTEGRATED INTO THIS WORK IS A COMPREHENSIVE EDUCATIONAL PLAN TOWARDS MEETING THE PI?S LONG-TERM EDUCATIONAL GOAL OF INCREASING SCIENCE, TECHNOLOGY, ENGINEERING, AND MATHEMATICS (STEM) AWARENESS AND PARTICIPATION OF UNDERREPRESENTED MINORITIES IN BIOMEDICAL RESEARCH AND CAREER PATHS. SPECIFIC EDUCATIONAL OBJECTIVES ARE TO: 1) PROMOTE STEM AND HEALTH AWARENESS THROUGH EDUCATIONAL AND COMMUNITY OUTREACH ACROSS GENERATIONS, FROM K-12 THROUGH GRAY POPULATIONS; AND 2) SUPPORT CROSS-DISCIPLINARY RESEARCH MENTORSHIP AND PROGRAMMING AT ALL LEVELS TO INCREASE THE NUMBER OF UNDERREPRESENTED MINORITY STUDENTS PURSUING GRADUATE DEGREES IN BIOMEDICAL ENGINEERING. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.

Posted 3/8/22, 12:00 AM